Category Archive for: ‘Remoxy’

‘Abuse-Resistant’ Form of OxyContin May Be Near

09.10.08Forbes.com THURSDAY, Sept. 11 (HealthDay News) — Researchers say they’ve developed an “abuse-resistant” formulation of the widely prescribed opioid pain medication OxyContin. The U.S. Food and Drug Administration has granted Remoxy priority review, meaning that action could come as soon as early December, said Dr. Nadav Friedman, chief operating officer of Pain Therapeutics Inc., which developed Remoxy. If approval is …

Read More

FDA Accepts REMOXY New Drug Application and Grants Priority Review

Fox Business, Tuesday, August 12, 2008 SAN MATEO, Calif. and BRISTOL, Tenn., Aug 12, 2008 /PRNewswire-FirstCall via COMTEX/ —-Pain Therapeutics, Inc. and King Pharmaceuticals, Inc. today announced that the New Drug Application (NDA) for REMOXY(r) was accepted and granted Priority Review by the U.S. Food and Drug Administration (FDA). The FDA typically grants Priority Review to drug candidates that have …

Read More